Cardiac electrophysiologists have many options for treating arrhythmias, including catheter ablation and implantable cardiac defibrillators. Antiarrhythmic agents, which are pharmaceutical agen
Atrial fibrillation is now present in nearly one percent of the general population and is expected to impact more than two percent of the industrialized world by the year 2050. This monograph by Kowey
